Pharma Insights Blog
Latest developments in pharmaceutical exports, import regulations, and healthcare trends across Central Asia, Caucasus, and Africa.
Market StatisticsWhich medicine groups are in demand in Kazakhstan, Azerbaijan and Uzbekistan? An import-data analysis
UN Comtrade and IQVIA data show general prescription medicines at the core of demand in all three countries; oncology stands out by value only in Kazakhstan.
Read More
Industry TrendsGenerics and biosimilars in oncology: is there a need and an opportunity in Central Asia?
What the evidence says on generic and biosimilar cancer medicines lowering prices, EAEU and Uzbek regulatory routes, and unmet need in Central Asia.
Read MoreMarket StatisticsAccess to and affordability of anticancer medicines in Kazakhstan, Azerbaijan and Uzbekistan: a comparative evidence review
Evidence review of cancer burden (GLOBOCAN 2024), oncology medicine financing and verified price and access data in Kazakhstan, Azerbaijan and Uzbekistan.
Read MoreRegulationsHow to Import Medicines into Kazakhstan: Rules for Buyers
How to import medicines into Kazakhstan: the Health Code's registration rule, who may import, and the exceptions for unregistered products, with sources.
Read More
RegulationsIncoterms 2020 for Pharmaceutical Exports: EXW, FCA, CIP or DAP?
Which Incoterms 2020 rule suits pharmaceutical exports? EXW, FCA, CPT/CIP and DAP/DDP explained, plus ICC notes on insurance in Kazakhstan and Azerbaijan.
Read More
RegulationsGDP Cold Chain 2-8°C: Pharmaceutical Transport Rules
How should medicines move in a 2-8°C cold chain? WHO and EU GDP rules on temperature mapping, qualified packaging, calibrated monitoring and excursions.
Read MoreRegulationsDocuments Required for Pharmaceutical Export from Turkey
Which documents are required for pharmaceutical export from Turkey? The WHO-format CPP, free sale certificate, batch certificate and ITS export notification.
Read MoreMarket StatisticsTurkey's Pharma Market in 2025: TRY 430.8 Billion and USD 2.51 Billion in Exports
According to İEİS, Turkey's pharmaceutical market grew 32.7% in value in 2025 to TRY 430.8 billion, while medicine exports rose 9.3% to USD 2.51 billion. Local production, import and biosimilar figures.
Read MoreMarket StatisticsKazakhstan's Domestic Pharma Output Reaches KZT 191.1 Billion
Pharmaceutical production in Kazakhstan rose 8.7% in 2025 to KZT 191.1 billion. The domestic share has reached about 40% in volume but only 16% in value; the target is 50% by 2029.
Read MoreIndustry TrendsFDA Approved 46 Novel Drugs in 2025: Half for Rare Diseases
The FDA's drug centre CDER approved 46 novel drugs in 2025; 43% were first-in-class and 50% had orphan drug designation. It also approved 18 biosimilars in the same year.
Read MoreIndustry TrendsIQVIA: Global Medicine Spending to Exceed USD 2.6 Trillion by 2030
According to the IQVIA Institute's 2026 report, global medicine spending will grow 5–8% a year and exceed USD 2.6 trillion by 2030. Oncology, immunology, diabetes and obesity drive the growth.
Read MoreRegulationsKazakhstan Lifts State Price Regulation on Medicines Priced Below 1 MRP
Under Kazakhstan Health Ministry Order No. 105 of 4 September 2026, medicines priced up to 1 MRP (4,325 tenge) moved to market pricing, cutting the regulated list from 3,039 to 1,827 positions.
Read MoreRegulationsEAEU Extends Medical Device Registration Under National Rules to End-2027
Under a protocol signed on 29 December 2025, EAEU states extended the deadline for registering medical devices under national legislation to 31 December 2027, and for re-registration and dossier changes to 31 December 2028.
Read More
RegulationsTürkiye: Medicinal Herbal Teas and Aromatherapy Products Now Pharmacy-Only
TİTCK regulations published in Official Gazette No. 33298 of 2 July 2026 bring medicinal herbal teas and aromatherapy products under licensing and QR-code tracking, and extend the licensing transition for foods for special medical purposes to 1 July 2027.
Read MoreRegulationsMandatory Medicine Marking in Kazakhstan: Rules for Importers
Since 1 July 2024 every medicine in Kazakhstan must carry a Data Matrix marking code. Where the code may be applied on imports and the EAEU pre-border notification rule.
Read MoreIndustry TrendsKazakhstan's New Tax Code: VAT on Medicines 5% in 2026, 10% in 2027
The new Tax Code in force since 1 January 2026 raised the standard VAT rate to 16%. The reduced rate for medicines and medical devices rises to 10% in 2027.
Read MoreRegulations2025 Amendments to Turkey's Licensing Regulation: New Key Date 1 January 2027
Turkey's Regulation on the Licensing of Human Medicinal Products was amended twice in 2025. Transition periods for radiopharmaceuticals, allergen products and clinical trials now run to 1 January 2027.
Read MoreMarket StatisticsMedicine Prices in Azerbaijan: Tariff Council Price Caps and Reference Countries
In Azerbaijan the Tariff (Price) Council sets maximum wholesale and retail prices for state-registered medicines. Türkiye is one of 10 reference countries.
Read More
RegulationsThe EAEU Common Medicines Market: The End-2025 Turning Point
In the EAEU, of which Kazakhstan is a member, bringing nationally registered medicines' dossiers into line with Union rules reached a critical threshold on 31 December 2025.
Read MoreRegulationsTurkey Updates the Euro Value in Drug Pricing (2026)
Decree No. 11031 of 12 March 2026 updated the euro value and adaptation coefficient used in drug pricing. Direct effects for pharmaceutical warehouses and importers.
Read MoreRegulationsGood Distribution Practices (GDP): The Backbone of the Supply Chain
TİTCK's Good Distribution and Storage Practices Guide governs procurement, storage, distribution and shipment for pharmaceutical warehouses. Cold chain and quality assurance.
Read MoreRegulationsDrug Tracking System (İTS): End-to-End Traceability with 2D Codes
In Turkey every medicine pack is tracked via a data-matrix code. Warehouses, pharmacies and exporters must register with İTS and report movements.
Read MoreRegulationsNew Medicine Registration Rules in Azerbaijan: Resolution No. 345
Azerbaijan Cabinet of Ministers Resolution No. 345 of 18 July 2024 renewed the medicine registration rules and repealed Resolution No. 108 of 2007.
Read MoreIndustry TrendsMedicine Serialization and Traceability in Azerbaijan: DVTIS
Azerbaijan introduced mandatory medicine serialization from 1 January 2024. The DVTIS system enables real-time tracking from production/import to the patient.
Read More